+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Bioprocess Automation Market Forecast to 2033

  • PDF Icon

    Report

  • 150 Pages
  • October 2025
  • Region: Global
  • Grand View Research
  • ID: 6189425
REQUEST CUSTOMIZATION
Description Jump to:
The global bioprocess automation market size was estimated at USD 7.76 billion in 2024 and is projected to reach USD 22.41 billion by 2033, growing at a CAGR of 12.67% from 2025 to 2033, driven by rising demand for biologics, advancements in AI and robotics, and the need for regulatory compliance and efficiency.

Rising Demand for Biologics

The rising demand for biologics is among the most significant drivers of the bioprocess automation industry. Over the past decade, there has been a sharp increase in the development and use of monoclonal antibodies, vaccines, gene therapies, and other biologic products due to their effectiveness in treating complex diseases, including cancer, autoimmune disorders, and rare genetic conditions. For these biologics to remain effective and to maintain high quality, manufacturing procedures must be extremely controlled, scalable, and precise. There is a significant need for fully automated bioprocess solutions because traditional manual or semi-automated production methods are frequently labor-intensive, prone to mistakes, and inadequate to meet the expanding market demand.

The need for bioprocess automation is anticipated to increase as the world's healthcare system depends more on biology for novel treatments, making it an essential part of contemporary pharmaceutical production. Automation in bioprocessing allows manufacturers to optimize production workflows, improve consistency, and increase throughput without compromising quality. Biopharmaceutical companies can produce larger biologics with reduced variability, faster turnaround times, and lower operational costs by integrating robotics, AI, and advanced monitoring systems.

Need for Efficiency and Cost Reduction

The need for cost and efficiency reduction largely drives the market for bioprocess automation. Manufacturing biopharmaceuticals is a complicated and resource-intensive process that frequently requires highly qualified staff, careful observation, and strict protocol adherence. Batch failures, inconsistent products, and higher production costs can result from labor-intensive, human error-prone manual or semi-automated processes. By implementing automated systems, businesses can increase productivity, decrease reliance on manual labor, and minimize errors, guaranteeing more consistent and dependable results across production batches.

Automation increases productivity, drastically reduces operating costs, and improves reliability. Manufacturers can more effectively meet growing market demand thanks to automated bioprocessing systems' ability to run continuously with little downtime, optimize resource usage, and speed up production cycles. In an increasingly cost-sensitive healthcare environment, the ability to produce high-quality biologics at a lower cost also helps businesses stay competitive. As a result, the need for cost-effectiveness and operational efficiency keeps driving global investments in bioprocess automation technologies.

Global Bioprocess Automation Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, the analyst has segmented the global bioprocess automation market report based on product & service, process stage, end use, and region:

Product & Service Outlook (Revenue, USD Million, 2021-2033)

  • Automation Consumables & Accessories
  • Process Automation Hardware
  • Software & Control Systems
  • Integrated & Turnkey Solutions
  • Services & Support

Process Stage Outlook (Revenue, USD Million, 2021-2033)

  • Upstream
  • Downstream
  • Process Development & Scale-up
  • Fill/Finish & Packaging automation
  • Quality Control & PAT

End Use Outlook (Revenue, USD Million, 2021-2033)

  • Pharmaceutical & biotech manufacturers
  • CDMOs & CMOs
  • Academic & research institutions
  • Contract testing & analytical labs
  • Others

Regional Outlook (Revenue, USD Million, 2021-2033)

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa (MEA)

Why You Should Buy This Report

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

Report Deliverables

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Product & Services
1.2.2. Process Stage
1.2.3. End Use
1.3. Information analysis
1.4. Market formulation & data visualization
1.5. Data validation & publishing
1.6. Information Procurement
1.6.1. Primary Research
1.7. Information or Data Analysis
1.8. Market Formulation & Validation
1.9. Market Details
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Ancillary Market Outlook
3.2. Market Trends and Outlook
3.3. Market Dynamics
3.3.1. Market Driver Impact Analysis
3.3.1.1. Rising demand for biologics
3.3.1.2. Need for efficiency and cost reduction
3.3.2. Market Restraint Impact Analysis
3.3.2.1. High Initial Investment Costs
3.3.2.2. Regulatory and Compliance Challenges
3.4. Business Environment Analysis
3.4.1. PESTLE Analysis
3.4.2. PORTER’S Five Forces Analysis
Chapter 4. Product & Services Business Analysis
4.1. Product & Services Segment Dashboard
4.2. Global Bioprocess Automation Market Product & Services, Movement Analysis
4.3. Global Bioprocess Automation Market Size & Trend Analysis, by Product & Services, 2021 to 2033 (USD Million)
4.4. Automation Consumables & Accessories
4.4.1. Global automation consumables & accessories market estimates and forecasts, 2021-2033 (USD Million)
4.5. Process Automation Hardware
4.5.1. Global Process Automation Hardware market estimates and forecasts, 2021-2033 (USD Million)
4.6. Software & Control Systems
4.6.1. Global software & control systems market estimates and forecasts, 2021-2033 (USD Million)
4.7. Integrated & Turnkey Solutions
4.7.1. Global integrated & turnkey solutions market estimates and forecasts, 2021-2033 (USD Million)
4.8. Services & Support
4.8.1. Global services & support market estimates and forecasts, 2021-2033 (USD Million)
Chapter 5. Process Stage Business Analysis
5.1. Process Stage Segment Dashboard
5.2. Global Bioprocess Automation Market Process Stage, Movement Analysis
5.3. Global Bioprocess Automation Market Size & Trend Analysis, by Process Stage, 2021 to 2033 (USD Million)
5.4. Upstream
5.4.1. Global upstream market estimates and forecasts, 2021-2033 (USD Million)
5.5. Downstream
5.5.1. Global downstream market estimates and forecasts, 2021-2033 (USD Million)
5.6. Process Development & Scale-up
5.6.1. Global process development & scale-up market estimates and forecasts, 2021-2033 (USD Million)
5.7. Fill/Finish & Packaging automation
5.7.1. Global fill/finish & packaging automation market estimates and forecasts, 2021-2033 (USD Million)
5.8. Quality Control & PAT
5.8.1. Global quality control & PAT market estimates and forecasts, 2021-2033 (USD Million)
Chapter 6. End Use Business Analysis
6.1. End Use Segment Dashboard
6.2. Global Bioprocess Automation Market End Use, Movement Analysis
6.3. Global Bioprocess Automation Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
6.4. Pharmaceutical & biotech manufacturers
6.4.1. Global Pharmaceutical & biotech manufacturers market estimates and forecasts, 2021-2033 (USD Million)
6.5. CDMOs & CMOs
6.5.1. Global CDMOs & CMOs market estimates and forecasts, 2021-2033 (USD Million)
6.6. Academic & research institutions
6.6.1. Global academic & research institutions market estimates and forecasts, 2021-2033 (USD Million)
6.7. Contract testing & analytical labs
6.7.1. Global contract testing & analytical labs market estimates and forecasts, 2021-2033 (USD Million)
6.8. Others
6.8.1. Global others market estimates and forecasts, 2021-2033 (USD Million)
Chapter 7. Bioprocess Automation Market: Regional Estimates and Trend Analysis, by Product, Product & Services, End Use, & End-Use
7.1. Regional Dashboard
7.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
7.3. North America
7.3.1. North America bioprocess automation market, 2021-2033 (USD Million)
7.3.2. U.S.
7.3.2.1. Key Country Dynamics
7.3.2.2. Target Disease Prevalence
7.3.2.3. Competitive Scenario
7.3.2.4. Regulatory Framework
7.3.2.5. U.S. bioprocess automation market, 2021-2033 (USD Million)
7.3.3. Canada
7.3.3.1. Key Country Dynamics
7.3.3.2. Target Disease Prevalence
7.3.3.3. Competitive Scenario
7.3.3.4. Regulatory Framework
7.3.3.5. Canada bioprocess automation market, 2021-2033 (USD Million)
7.3.4. Mexico
7.3.4.1. Key Country Dynamics
7.3.4.2. Target Disease Prevalence
7.3.4.3. Competitive Scenario
7.3.4.4. Regulatory Framework
7.3.4.5. Mexico bioprocess automation market, 2021-2033 (USD Million)
7.4. Europe
7.4.1. Europe bioprocess automation market, 2021-2033 (USD Million)
7.4.2. UK
7.4.2.1. Key Country Dynamics
7.4.2.2. Target Disease Prevalence
7.4.2.3. Competitive Scenario
7.4.2.4. Regulatory Framework
7.4.2.5. UK bioprocess automation market, 2021-2033 (USD Million)
7.4.3. Germany
7.4.3.1. Key Country Dynamics
7.4.3.2. Target Disease Prevalence
7.4.3.3. Competitive Scenario
7.4.3.4. Regulatory Framework
7.4.3.5. Germany bioprocess automation market, 2021-2033 (USD Million)
7.4.4. France
7.4.4.1. Key Country Dynamics
7.4.4.2. Target Disease Prevalence
7.4.4.3. Competitive Scenario
7.4.4.4. Regulatory Framework
7.4.4.5. France bioprocess automation market, 2021-2033 (USD Million)
7.4.5. Italy
7.4.5.1. Key Country Dynamics
7.4.5.2. Target Disease Prevalence
7.4.5.3. Competitive Scenario
7.4.5.4. Regulatory Framework
7.4.5.5. Italy bioprocess automation market, 2021-2033 (USD Million)
7.4.6. Spain
7.4.6.1. Key Country Dynamics
7.4.6.2. Target Disease Prevalence
7.4.6.3. Competitive Scenario
7.4.6.4. Regulatory Framework
7.4.6.5. Spain bioprocess automation market, 2021-2033 (USD Million)
7.4.7. Denmark
7.4.7.1. Key Country Dynamics
7.4.7.2. Target Disease Prevalence
7.4.7.3. Competitive Scenario
7.4.7.4. Regulatory Framework
7.4.7.5. Denmark bioprocess automation market, 2021-2033 (USD Million)
7.4.8. Sweden
7.4.8.1. Key Country Dynamics
7.4.8.2. Target Disease Prevalence
7.4.8.3. Competitive Scenario
7.4.8.4. Regulatory Framework
7.4.8.5. Sweden bioprocess automation market, 2021-2033 (USD Million)
7.4.9. Norway
7.4.9.1. Key Country Dynamics
7.4.9.2. Target Disease Prevalence
7.4.9.3. Competitive Scenario
7.4.9.4. Regulatory Framework
7.4.9.5. Norway bioprocess automation market, 2021-2033 (USD Million)
7.5. Asia-Pacific
7.5.1. Asia-Pacific bioprocess automation market, 2021-2033 (USD Million)
7.5.2. Japan
7.5.2.1. Key Country Dynamics
7.5.2.2. Target Disease Prevalence
7.5.2.3. Competitive Scenario
7.5.2.4. Regulatory Framework
7.5.2.5. Japan bioprocess automation market, 2021-2033 (USD Million)
7.5.3. China
7.5.3.1. Key Country Dynamics
7.5.3.2. Target Disease Prevalence
7.5.3.3. Competitive Scenario
7.5.3.4. Regulatory Framework
7.5.3.5. China bioprocess automation market, 2021-2033 (USD Million)
7.5.4. India
7.5.4.1. Key Country Dynamics
7.5.4.2. Target Disease Prevalence
7.5.4.3. Competitive Scenario
7.5.4.4. Regulatory Framework
7.5.4.5. India bioprocess automation market, 2021-2033 (USD Million)
7.5.5. Australia
7.5.5.1. Key Country Dynamics
7.5.5.2. Target Disease Prevalence
7.5.5.3. Competitive Scenario
7.5.5.4. Regulatory Framework
7.5.5.5. Australia bioprocess automation market, 2021-2033 (USD Million)
7.5.6. Thailand
7.5.6.1. Key Country Dynamics
7.5.6.2. Target Disease Prevalence
7.5.6.3. Competitive Scenario
7.5.6.4. Regulatory Framework
7.5.6.5. Thailand bioprocess automation market, 2021-2033 (USD Million)
7.5.7. South Korea
7.5.7.1. Key Country Dynamics
7.5.7.2. Target Disease Prevalence
7.5.7.3. Competitive Scenario
7.5.7.4. Regulatory Framework
7.5.7.5. South Korea bioprocess automation market, 2021-2033 (USD Million)
7.6. Latin America
7.6.1. Latin America bioprocess automation market, 2021-2033 (USD Million)
7.6.2. Brazil
7.6.2.1. Key Country Dynamics
7.6.2.2. Target Disease Prevalence
7.6.2.3. Competitive Scenario
7.6.2.4. Regulatory Framework
7.6.2.5. Brazil bioprocess automation market, 2021-2033 (USD Million)
7.6.3. Argentina
7.6.3.1. Key Country Dynamics
7.6.3.2. Target Disease Prevalence
7.6.3.3. Competitive Scenario
7.6.3.4. Regulatory Framework
7.6.3.5. Argentina bioprocess automation market, 2021-2033 (USD Million)
7.7. MEA
7.7.1. MEA bioprocess automation market, 2021-2033 (USD Million)
7.7.2. South Africa
7.7.2.1. Key Country Dynamics
7.7.2.2. Target Disease Prevalence
7.7.2.3. Competitive Scenario
7.7.2.4. Regulatory Framework
7.7.2.5. South Africa bioprocess automation market, 2021-2033 (USD Million)
7.7.3. Saudi Arabia
7.7.3.1. Key Country Dynamics
7.7.3.2. Target Disease Prevalence
7.7.3.3. Competitive Scenario
7.7.3.4. Regulatory Framework
7.7.3.5. Saudi Arabia bioprocess automation market, 2021-2033 (USD Million)
7.7.4. UAE
7.7.4.1. Key Country Dynamics
7.7.4.2. Target Disease Prevalence
7.7.4.3. Competitive Scenario
7.7.4.4. Regulatory Framework
7.7.4.5. UAE bioprocess automation market, 2021-2033 (USD Million)
7.7.5. Kuwait
7.7.5.1. Key Country Dynamics
7.7.5.2. Target Disease Prevalence
7.7.5.3. Competitive Scenario
7.7.5.4. Regulatory Framework
7.7.5.5. Kuwait bioprocess automation market, 2021-2033 (USD Million)
Chapter 8. Competitive Landscape
8.1. Company Categorization
8.2. Strategy Mapping
8.3. Company Market Position Analysis, 2024
8.4. Company Profiles/Listing
8.4.1. Thermo Fisher Scientific Inc.
8.4.1.1. Overview
8.4.1.2. Financial Performance
8.4.1.3. Product Benchmarking
8.4.1.4. Strategic Initiatives
8.4.2. Sartorius AG
8.4.2.1. Overview
8.4.2.2. Financial Performance
8.4.2.3. Product Benchmarking
8.4.2.4. Strategic Initiatives
8.4.3. Parker Hannifin Corp
8.4.3.1. Overview
8.4.3.2. Financial Performance
8.4.3.3. Product Benchmarking
8.4.3.4. Strategic Initiatives
8.4.4. Merck KGaA
8.4.4.1. Overview
8.4.4.2. Financial Performance
8.4.4.3. Product Benchmarking
8.4.4.4. Strategic Initiatives
8.4.5. Eppendorf SE
8.4.5.1. Overview
8.4.5.2. Financial Performance
8.4.5.3. Product Benchmarking
8.4.5.4. Strategic Initiatives
8.4.6. SIA Bioreactors.net
8.4.6.1. Overview
8.4.6.2. Product Benchmarking
8.4.6.3. Strategic Initiatives
8.4.7. Senieer
8.4.7.1. Overview
8.4.7.2. Product Benchmarking
8.4.7.3. Strategic Initiatives
8.4.8. Getinge
8.4.8.1. Overview
8.4.8.2. Financial Performance
8.4.8.3. Product Benchmarking
8.4.8.4. Strategic Initiatives
8.4.9. Repligen Corporation
8.4.9.1. Overview
8.4.9.2. Financial Performance
8.4.9.3. Product Benchmarking
8.4.9.4. Strategic Initiatives
List of Tables
Table 1. List of Secondary Sources
Table 2. List of Abbreviations
Table 3. Global Bioprocess Automation Market, by Product & Services, 2021-2033 (USD Million)
Table 4. Global Bioprocess Automation Market, by Process Stage, 2021-2033 (USD Million)
Table 5. Global Bioprocess Automation Market, by End Use, 2021-2033 (USD Million)
Table 6. Global Bioprocess Automation Market, by Region, 2021-2033 (USD Million)
Table 7. North America Bioprocess Automation Market, by Country, 2021-2033 (USD Million)
Table 8. North America Bioprocess Automation Market, by Product & Services, 2021-2033 (USD Million)
Table 9. North America Bioprocess Automation Market, by Process Stage, 2021-2033 (USD Million)
Table 10. North America Bioprocess Automation Market, by End Use, 2021-2033 (USD Million)
Table 11. U.S. Bioprocess Automation Market, by Product & Services, 2021-2033 (USD Million)
Table 12. U.S. Bioprocess Automation Market, by Process Stage, 2021-2033 (USD Million)
Table 13. U.S. Bioprocess Automation Market, by End Use, 2021-2033 (USD Million)
Table 14. Canada Bioprocess Automation Market, by Product & Services, 2021-2033 (USD Million)
Table 15. Canada Bioprocess Automation Market, by Process Stage, 2021-2033 (USD Million)
Table 16. Canada Bioprocess Automation Market, by End Use, 2021-2033 (USD Million)
Table 17. Mexico Bioprocess Automation Market, by Product & Services, 2021-2033 (USD Million)
Table 18. Mexico Bioprocess Automation Market, by Process Stage, 2021-2033 (USD Million)
Table 19. Mexico Bioprocess Automation Market, by End Use, 2021-2033 (USD Million)
Table 20. Europe Bioprocess Automation Market, by Country, 2021-2033 (USD Million)
Table 21. Europe Bioprocess Automation Market, by Product & Services, 2021-2033 (USD Million)
Table 22. Europe Bioprocess Automation Market, by Process Stage, 2021-2033 (USD Million)
Table 23. Europe Bioprocess Automation Market, by End Use, 2021-2033 (USD Million)
Table 24. Germany Bioprocess Automation Market, by Product & Services, 2021-2033 (USD Million)
Table 25. Germany Bioprocess Automation Market, by Process Stage, 2021-2033 (USD Million)
Table 26. Germany Bioprocess Automation Market, by End Use, 2021-2033 (USD Million)
Table 27. UK Bioprocess Automation Market, by Product & Services, 2021-2033 (USD Million)
Table 28. UK Bioprocess Automation Market, by Process Stage, 2021-2033 (USD Million)
Table 29. UK Bioprocess Automation Market, by End Use, 2021-2033 (USD Million)
Table 30. France Bioprocess Automation Market, by Product & Services, 2021-2033 (USD Million)
Table 31. France Bioprocess Automation Market, by Process Stage, 2021-2033 (USD Million)
Table 32. France Bioprocess Automation Market, by End Use, 2021-2033 (USD Million)
Table 33. Italy Bioprocess Automation Market, by Product & Services, 2021-2033 (USD Million)
Table 34. Italy Bioprocess Automation Market, by Process Stage, 2021-2033 (USD Million)
Table 35. Italy Bioprocess Automation Market, by End Use, 2021-2033 (USD Million)
Table 36. Spain Bioprocess Automation Market, by Product & Services, 2021-2033 (USD Million)
Table 37. Spain Bioprocess Automation Market, by Process Stage, 2021-2033 (USD Million)
Table 38. Spain Bioprocess Automation Market, by End Use, 2021-2033 (USD Million)
Table 39. Denmark Bioprocess Automation Market, by Product & Services, 2021-2033 (USD Million)
Table 40. Denmark Bioprocess Automation Market, by Process Stage, 2021-2033 (USD Million)
Table 41. Denmark Bioprocess Automation Market, by End Use, 2021-2033 (USD Million)
Table 42. Norway Bioprocess Automation Market, by Product & Services, 2021-2033 (USD Million)
Table 43. Norway Bioprocess Automation Market, by Process Stage, 2021-2033 (USD Million)
Table 44. Norway Bioprocess Automation Market, by End Use, 2021-2033 (USD Million)
Table 45. Sweden Bioprocess Automation Market, by Product & Services, 2021-2033 (USD Million)
Table 46. Sweden Bioprocess Automation Market, by Process Stage, 2021-2033 (USD Million)
Table 47. Sweden Bioprocess Automation Market, by End Use, 2021-2033 (USD Million)
Table 48. Asia-Pacific Bioprocess Automation Market, by Country, 2021-2033 (USD Million)
Table 49. Asia-Pacific Bioprocess Automation Market, by Product & Services, 2021-2033 (USD Million)
Table 50. Asia-Pacific Bioprocess Automation Market, by Process Stage, 2021-2033 (USD Million)
Table 51. Asia-Pacific Bioprocess Automation Market, by End Use, 2021-2033 (USD Million)
Table 52. China Bioprocess Automation Market, by Product & Services, 2021-2033 (USD Million)
Table 53. China Bioprocess Automation Market, by Process Stage, 2021-2033 (USD Million)
Table 54. China Bioprocess Automation Market, by End Use, 2021-2033 (USD Million)
Table 55. Japan Bioprocess Automation Market, by Product & Services, 2021-2033 (USD Million)
Table 56. Japan Bioprocess Automation Market, by Process Stage, 2021-2033 (USD Million)
Table 57. Japan Bioprocess Automation Market, by End Use, 2021-2033 (USD Million)
Table 58. India Bioprocess Automation Market, by Product & Services, 2021-2033 (USD Million)
Table 59. India Bioprocess Automation Market, by Process Stage, 2021-2033 (USD Million)
Table 60. India Bioprocess Automation Market, by End Use, 2021-2033 (USD Million)
Table 61. South Korea Bioprocess Automation Market, by Product & Services, 2021-2033 (USD Million)
Table 62. South Korea Bioprocess Automation Market, by Process Stage, 2021-2033 (USD Million)
Table 63. South Korea Bioprocess Automation Market, by End Use, 2021-2033 (USD Million)
Table 64. Australia Bioprocess Automation Market, by Product & Services, 2021-2033 (USD Million)
Table 65. Australia Bioprocess Automation Market, by Process Stage, 2021-2033 (USD Million)
Table 66. Australia Bioprocess Automation Market, by End Use, 2021-2033 (USD Million)
Table 67. Thailand Bioprocess Automation Market, by Product & Services, 2021-2033 (USD Million)
Table 68. Thailand Bioprocess Automation Market, by Process Stage, 2021-2033 (USD Million)
Table 69. Thailand Bioprocess Automation Market, by End Use, 2021-2033 (USD Million)
Table 70. Latin America Bioprocess Automation Market, by Country, 2021-2033 (USD Million)
Table 71. Latin America Bioprocess Automation Market, by Product & Services, 2021-2033 (USD Million)
Table 72. Latin America Bioprocess Automation Market, by Process Stage, 2021-2033 (USD Million)
Table 73. Latin America Bioprocess Automation Market, by End Use, 2021-2033 (USD Million)
Table 74. Brazil Bioprocess Automation Market, by Product & Services, 2021-2033 (USD Million)
Table 75. Brazil Bioprocess Automation Market, by Process Stage, 2021-2033 (USD Million)
Table 76. Brazil Bioprocess Automation Market, by End Use, 2021-2033 (USD Million)
Table 77. Argentina Bioprocess Automation Market, by Product & Services, 2021-2033 (USD Million)
Table 78. Argentina Bioprocess Automation Market, by Process Stage, 2021-2033 (USD Million)
Table 79. Argentina Bioprocess Automation Market, by End Use, 2021-2033 (USD Million)
Table 80. Middle East and Africa Bioprocess Automation Market, by Country, 2021-2033 (USD Million)
Table 81. Middle East and Africa Bioprocess Automation Market, by Product & Services, 2021-2033 (USD Million)
Table 82. Middle East and Africa Bioprocess Automation Market, by Process Stage, 2021-2033 (USD Million)
Table 83. Middle East and Africa Bioprocess Automation Market, by End Use, 2021-2033 (USD Million)
Table 84. South Africa Bioprocess Automation Market, by Product & Services, 2021-2033 (USD Million)
Table 85. South Africa Bioprocess Automation Market, by Process Stage, 2021-2033 (USD Million)
Table 86. South Africa Bioprocess Automation Market, by End Use, 2021-2033 (USD Million)
Table 87. Saudi Arabia Bioprocess Automation Market, by Product & Services, 2021-2033 (USD Million)
Table 88. Saudi Arabia Bioprocess Automation Market, by Process Stage, 2021-2033 (USD Million)
Table 89. Saudi Arabia Bioprocess Automation Market, by End Use, 2021-2033 (USD Million)
Table 90. UAE Bioprocess Automation Market, by Product & Services, 2021-2033 (USD Million)
Table 91. UAE Bioprocess Automation Market, by Process Stage, 2021-2033 (USD Million)
Table 92. UAE Bioprocess Automation Market, by End Use, 2021-2033 (USD Million)
Table 93. Kuwait Bioprocess Automation Market, by Product & Services, 2021-2033 (USD Million)
Table 94. Kuwait Bioprocess Automation Market, by Process Stage, 2021-2033 (USD Million)
Table 95. Kuwait Bioprocess Automation Market, by End Use, 2021-2033 (USD Million)
List of Figures
Figure 1 Bioprocess automation market segmentation
Figure 2 Data analysis models
Figure 3 Market formulation and validation
Figure 4 Data validation & publishing
Figure 5 Market research process
Figure 6 Information procurement
Figure 7 Primary research
Figure 8 Value-chain-based sizing & forecasting
Figure 9 QFD modelling for market share assessment
Figure 10 Market formulation & validation
Figure 11 Commodity flow analysis
Figure 12 Market outlook
Figure 13 Segment snapshot-1
Figure 14 Competitive landscape snapshot
Figure 15 Market trends & outlook
Figure 16 PESTEL analysis
Figure 17 Porter’s five forces analysis
Figure 18 Bioprocess automation market: Product & Services outlook key takeaways
Figure 19 Bioprocess automation market: Product & Services movement analysis
Figure 20 Automation consumables & accessories market, 2021-2033 (USD Million)
Figure 21 Process automation hardware market, 2021-2033 (USD Million)
Figure 22 Software & control systems market, 2021-2033 (USD Million)
Figure 23 Integrated & turnkey solutions market, 2021-2033 (USD Million)
Figure 24 Services & support market, 2021-2033 (USD Million)
Figure 25 Bioprocess automation market: Process Stage outlook key takeaways
Figure 26 Bioprocess automation market: Process Stage movement analysis
Figure 27 Upstream market, 2021-2033 (USD Million)
Figure 28 Downstream market, 2021-2033 (USD Million)
Figure 29 Process development & scale-up market, 2021-2033 (USD Million)
Figure 30 Fill/finish & packaging automation market, 2021-2033 (USD Million)
Figure 31 Quality control & PAT market, 2021-2033 (USD Million)
Figure 32 Bioprocess automation market: End Use outlook key takeaways
Figure 33 Bioprocess automation market: End Use movement analysis
Figure 34 Pharmaceutical & biotech manufacturers market, 2021-2033 (USD Million)
Figure 35 CDMOs & CMOs market, 2021-2033 (USD Million)
Figure 36 Academic & research institutions market, 2021-2033 (USD Million)
Figure 37 Contract testing & analytical labs market, 2021-2033 (USD Million)
Figure 38 Others market, 2021-2033 (USD Million)
Figure 39 Regional marketplace outlook, 2024 & 2033 (USD Million)
Figure 40 Regional marketplace: Key takeaways
Figure 41 North America bioprocess automation market estimates and forecast, 2021-2033 (USD Million)
Figure 42 Key country dynamics
Figure 43 U.S. bioprocess automation market estimates and forecast, 2021-2033 (USD Million)
Figure 44 Key country dynamics
Figure 45 Canada bioprocess automation market estimates and forecast, 2021-2033 (USD Million)
Figure 46 Key country dynamics
Figure 47 Mexico bioprocess automation market estimates and forecast, 2021-2033 (USD Million)
Figure 48 Europe bioprocess automation market estimates and forecast, 2021-2033 (USD Million)
Figure 49 Key country dynamics
Figure 50 Germany bioprocess automation market estimates and forecast, 2021-2033 (USD Million)
Figure 51 Key country dynamics
Figure 52 UK bioprocess automation market estimates and forecast, 2021-2033 (USD Million)
Figure 53 Key country dynamics
Figure 54 France bioprocess automation market estimates and forecast, 2021-2033 (USD Million)
Figure 55 Key country dynamics
Figure 56 Italy bioprocess automation market estimates and forecast, 2021-2033 (USD Million)
Figure 57 Key country dynamics
Figure 58 Spain bioprocess automation market estimates and forecast, 2021-2033 (USD Million)
Figure 59 Key country dynamics
Figure 60 Denmark bioprocess automation market estimates and forecast, 2021-2033 (USD Million)
Figure 61 Key country dynamics
Figure 62 Sweden bioprocess automation market estimates and forecast, 2021-2033 (USD Million)
Figure 63 Key country dynamics
Figure 64 Norway bioprocess automation market estimates and forecast, 2021-2033 (USD Million)
Figure 65 Asia-Pacific bioprocess automation market estimates and forecast, 2021-2033 (USD Million)
Figure 66 Key country dynamics
Figure 67 Japan bioprocess automation market estimates and forecasts, 2021-2033 (USD Million)
Figure 68 Key country dynamics
Figure 69 China bioprocess automation market estimates and forecasts, 2021-2033 (USD Million)
Figure 70 Key country dynamics
Figure 71 India bioprocess automation market estimates and forecasts, 2021-2033 (USD Million)
Figure 72 Key country dynamics
Figure 73 South Korea bioprocess automation market estimates and forecasts, 2021-2033 (USD Million)
Figure 74 Key country dynamics
Figure 75 Australia bioprocess automation market estimates and forecasts, 2021-2033 (USD Million)
Figure 76 Key country dynamics
Figure 77 Thailand bioprocess automation market estimates and forecasts, 2021-2033 (USD Million)
Figure 78 Latin America bioprocess automation market estimates and forecasts, 2021-2033 (USD Million)
Figure 79 Key country dynamics
Figure 80 Brazil bioprocess automation market estimates and forecasts, 2021-2033 (USD Million)
Figure 81 Key country dynamics
Figure 82 Argentina bioprocess automation market estimates and forecasts, 2021-2033 (USD Million)
Figure 83 MEA bioprocess automation market estimates and forecasts, 2021-2033 (USD Million)
Figure 84 Key country dynamics
Figure 85 South Africa bioprocess automation market estimates and forecasts, 2021-2033 (USD Million)
Figure 86 Key country dynamics
Figure 87 Saudi Arabia bioprocess automation market estimates and forecasts, 2021-2033 (USD Million)
Figure 88 Key country dynamics
Figure 89 UAE bioprocess automation market estimates and forecasts, 2021-2033 (USD Million)
Figure 90 Key country dynamics
Figure 91 Kuwait bioprocess automation market estimates and forecasts, 2021-2033 (USD Million)
Figure 92 Market position analysis
Figure 93 Market participant categorization
Figure 94 Strategic framework

Companies Mentioned

The companies profiled in this Bioprocess Automation market report include:
  • Thermo Fisher Scientific Inc.
  • Sartorius AG
  • Parker Hannifin Corp
  • Danaher
  • Merck KGaA
  • Eppendorf SE
  • SIA Bioreactors.net
  • Senieer
  • Getinge
  • Repligen Corporation

Table Information

Report AttributeDetails
No. of Pages150
PublishedOctober 2025
Forecast Period2024 - 2033
Estimated Market Value ( USD ) in 2024 $ 7.76 Billion
Forecasted Market Value ( USD ) by 2033 $ 22.41 Billion
Compound Annual Growth Rate12.6%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Bioprocess Validation Market Size, Share & Trends Analysis Report by Testing Type (Extractables & Leachables Testing, Bioprocess Residuals Testing), Stage (Process Design, Process Qualification), Mode, and Region with Growth Forecasts, 2025-2033 - Product Image

Bioprocess Validation Market Size, Share & Trends Analysis Report by Testing Type (Extractables & Leachables Testing, Bioprocess Residuals Testing), Stage (Process Design, Process Qualification), Mode, and Region with Growth Forecasts, 2025-2033

  • Report
  • 130 Pages
  • Global
From
Bioprocess Validation Market Size, Share, Trends and Forecast by Test Type, Process Component, End User, and Region, 2025-2033 - Product Image

Bioprocess Validation Market Size, Share, Trends and Forecast by Test Type, Process Component, End User, and Region, 2025-2033

  • Report
  • 141 Pages
  • Global
From
Global Bioprocess Validation Market: Focus on End Users, Product, Test Type, Region and Competitive Landscape - Analysis and Forecast, 2024-2033 - Product Image

Global Bioprocess Validation Market: Focus on End Users, Product, Test Type, Region and Competitive Landscape - Analysis and Forecast, 2024-2033

  • Report
  • 147 Pages
  • Global
From
Bioprocess Validation Market Report 2023-2033 - Product Image

Bioprocess Validation Market Report 2023-2033

  • Report
  • 315 Pages
  • Global
From
Bioprocess Optimization and Digital Bio-manufacturing: Global Markets - Product Image

Bioprocess Optimization and Digital Bio-manufacturing: Global Markets

  • Report
  • 180 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.